Roberts D D
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Am J Respir Cell Mol Biol. 1990 Sep;3(3):181-6. doi: 10.1165/ajrcmb/3.3.181.
Adhesion of pathogens to proteins and glycoconjugates on the host cell plasma membrane or to components of the extracellular matrix is a critical early step in the initiation of infection. For intracellular pathogens, adhesion to the cell surface is a prerequisite to gaining entry into the cell. In all cases, adhesion to host tissue prevents elimination of the pathogens by normal clearance processes and may help the organism to evade immune surveillance by the host. Many laboratories are investigating the ligand binding specificities of bacterial receptors or adhesions and have described diverse binding specificities for adhesive proteins in the host extracellular matrix including laminin and fibronectin. Many bacteria also have adhesins that bind to carbohydrates occurring on glycolipids and glycoproteins in the apical membranes of epithelia in tissues that are targets for infection. Definition of these binding specificities and identification of the receptors that mediate adhesion may lead to development of a novel class of antibiotics whose mechanism of action is to compete with the endogenous ligands for binding to the pathogen receptors or to otherwise prevent adhesion to host tissues and thereby prevent infection.
病原体与宿主细胞质膜上的蛋白质和糖缀合物或细胞外基质成分的粘附是感染起始的关键早期步骤。对于细胞内病原体而言,粘附于细胞表面是进入细胞的先决条件。在所有情况下,粘附于宿主组织可防止病原体通过正常清除过程被清除,并可能有助于病原体逃避宿主的免疫监视。许多实验室正在研究细菌受体或粘附素的配体结合特异性,并已描述了其对宿主细胞外基质中包括层粘连蛋白和纤连蛋白在内的粘附蛋白的多种结合特异性。许多细菌还具有粘附素,可与感染靶组织上皮顶端膜中糖脂和糖蛋白上的碳水化合物结合。这些结合特异性的定义以及介导粘附的受体的鉴定可能会导致开发出一类新型抗生素,其作用机制是与内源性配体竞争与病原体受体的结合,或以其他方式防止粘附于宿主组织,从而预防感染。